Skip to main content Back to Top
Advertisement

Person-Centered Care for Vulnerable Populations Part 1

Broadcast Date: January 12, 2023

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This three-part podcast series is a follow up to the June 2022 ASHP continuing education webinar, “Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care”. Each podcast series will feature one webinar speaker with additional information about working with the medically underserved, refugees & immigrants, and sexual & gender minorities.

SPEAKERS

Cassie HeffernCassie Heffern, PharmD, BCACP became an ambulatory care pharmacy specialist at CoxHealth in Springfield, Missouri in 2014. She has served as the PGY2 residency program director since 2015. Her practice site is the Family Medical Care Center, which is a patient centered medical home that houses the Cox Family Medicine Residency. Her site responsibilities include collaborative chronic disease state management utilizing a collaborative practice agreement, assisting with access barriers to medications, and closing population health care gaps.

Carleigh KruegerCarleigh Krueger, PharmD, BCACP is the pharmacist in charge of the Salina Regional Health Center Outpatient Pharmacy in Salina, KS. She received her PharmD from the University of Kansas, completed a PGY1 Residency at SRHC, then stayed on to start their Meds to Beds program. She precepts residents, APPE and IPPE pharmacy students, and serves as adjunct faculty at the KU-Salina School of Medicine. Her clinical interests include technician development, psychiatry, cardiology, and transitions of care.

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.